Changing to Avastin could save NHS £100m a year - Cameron Optometry | Cameron Optometry
Changing to Avastin could save NHS £100m a year

Changing to Avastin could save NHS £100m a year

Posted on 25th November 2014

The drug Avastin has been in the newscalling for its use in the UK in a bid to save millions each year.

eye-care

Popular in the US, Avastin is used for patients with age-related macular degeneration (AMD). It has been on the market for years, gone through all the testing and has been proven to be as effective as Lucentis, the NHS approved drug for the same condition. The difference is cost. Lucentis typically costs around £700 per treatment, compared to Avastin which is about £70. Yet red tape seems to be halting its use.

It is currently unlicensed in the UK so should anything go wrong with its use, the practitioner may not be legally covered. However, in times of austerity and it is perhaps time for the NHS to move forward and license its use.


Related Posts

Back to school eye examination

16th August 2018

We hope the start of the new term is going well for all who went back this week. Did you manage to get your child's eyes examined over the holidays? Children should have their eyes examined by an opto...

Read more

Win New Glasses For The New Term

31st July 2018

New uniform. New shoes. New pencil case. New bag. What about some new glasses to make sure your child looks super smart when they go back to school? We are offering your child, the chance to win their...

Read more

Gillian Bruce completes masters as top performing student

18th June 2018

We’re thrilled to announce that our clinical lead optometrist, Gillian Bruce, has passed her Masters of Science (MSc) degree in Primary Care Ophthalmology with distinction. As if that wasn’t impre...

Read more

Update: Our successful Myopia Management programme

24th May 2018

When we first wrote in our blog about Myopia Management over two years ago, it was all quite new. Cameron Optometry was one of the first optometrists in the UK to set up a Myopia Management programme ...

Read more